Medication Tips for Protecting Kidney Health in Diabetic Patients

Understanding the Critical Connection Between Diabetes and Kidney Health

People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Managing medication effectively is one of the most important strategies for protecting kidney health in diabetic patients. With proper understanding and use of medications, individuals with diabetes can significantly reduce their risk of developing kidney disease or slow its progression if it has already begun.

Diabetic kidney disease is the primary etiology of end-stage kidney disease in diabetic patients, accounting for 30–50% of ESKD cases globally. This sobering statistic underscores the importance of proactive medication management and comprehensive care strategies. The good news is that recent advances in diabetes and kidney disease treatment have provided healthcare providers and patients with more effective tools than ever before.

This comprehensive guide will explore essential medication tips for protecting kidney health in diabetic patients, covering everything from understanding your prescriptions to monitoring kidney function, avoiding harmful medications, and embracing the latest therapeutic advances that can make a real difference in long-term outcomes.

The Importance of Understanding Your Medications

Knowledge is power when it comes to medication management. Understanding why you take each medication, how it works, and what to expect can dramatically improve adherence and outcomes. For diabetic patients concerned about kidney health, several categories of medications play crucial roles.

Blood Sugar Control Medications

Maintaining optimal blood glucose levels is fundamental to preventing or slowing diabetic kidney disease. Strict glycemic control has been shown to delay the progression of diabetes-related microvascular complications, with tight glycemic control delaying the progression of diabetic nephropathy. Your diabetes medications work to keep blood sugar within target ranges, reducing the damage that elevated glucose can cause to the delicate filtering units in your kidneys.

Different diabetes medications work through various mechanisms. Some stimulate insulin production, others improve insulin sensitivity, and newer classes work through entirely different pathways. Understanding which category your medication falls into helps you recognize why your doctor chose that particular treatment and what benefits it provides beyond simple blood sugar control.

Blood Pressure Medications for Kidney Protection

Both systolic and diastolic hypertension accelerate the progression of nephropathy, and tight blood pressure control reduced the risk of death and complications related to diabetes mellitus. Blood pressure management is not just about preventing strokes and heart attacks—it's also critical for preserving kidney function.

Certain blood pressure medications offer specific kidney-protective benefits beyond their blood pressure-lowering effects. Treatment with an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) should be initiated in patients with diabetes, hypertension, and albuminuria, and these medications should be titrated to the highest approved dose that is tolerated. These medications work by blocking hormones that can damage kidney tissue and increase protein leakage into the urine.

Kidney-Protective Medications

Beyond traditional blood sugar and blood pressure medications, several newer drug classes have demonstrated remarkable kidney-protective properties. SGLT2 inhibitors and Finerenone are kidney protective, and if you have type 2 diabetes and kidney disease or early-stage kidney disease, you need to know about these medications. These medications represent a paradigm shift in how we approach diabetic kidney disease, offering protection through multiple mechanisms.

Understanding that your medication regimen likely includes drugs from multiple categories—each serving a specific purpose in your overall kidney protection strategy—helps you appreciate why taking all prescribed medications as directed is so important. Each medication plays a unique role in a comprehensive defense against kidney disease progression.

First-Line Medications: ACE Inhibitors and ARBs

The renin–angiotensin–aldosterone system (RAAS) blockade, with angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB), was the sole treatment option for diabetic kidney disease (DKD) for about 20 years. These medications have stood the test of time and remain cornerstone therapies for diabetic kidney disease.

How ACE Inhibitors and ARBs Protect Your Kidneys

Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors are known to reduce proteinuria and have been the first-line agents in the management of diabetic nephropathy for the past 20 years. These medications work by interrupting the renin-angiotensin-aldosterone system, a hormonal cascade that affects blood pressure and kidney function.

When you have diabetes, this hormonal system can become overactive, leading to increased pressure within the kidney's filtering units and causing protein to leak into the urine—a condition called proteinuria or albuminuria. ACE inhibitors and ARBs help relax blood vessels, reduce pressure in the kidneys, and decrease protein leakage, all of which help preserve kidney function over time.

In people with type 1 diabetes, along with hypertension or other signs of kidney disease, ACE inhibitors can help slow the progression of nephropathy. Similarly, ARBs may be better at delaying the progression of those with type 2 diabetes along with hypertension and kidney disease. Both medication classes have proven effective, and your doctor will choose the most appropriate option based on your individual circumstances.

Evidence Supporting ACE Inhibitors and ARBs

The evidence supporting these medications is substantial. ACE inhibitors reduced the incidence of end-stage renal disease by 40 percent, and ARBs reduced this progression by 22 percent. These are significant reductions that translate to real-world benefits: fewer patients requiring dialysis or kidney transplantation.

ACEi may prevent kidney failure. Similarly, ARB may prevent kidney failure, doubling of serum creatinine, and the progression from microalbuminuria to macroalbuminuria. These medications don't just slow kidney disease—they can actually prevent progression to more severe stages.

Important Monitoring Considerations

While ACE inhibitors and ARBs are highly beneficial, they require careful monitoring. When starting one of these medications, it is important to monitor the serum creatinine and potassium within 2–4 weeks after starting this medication or changing the dose, monitoring for a medication-induced change in serum creatinine that is >30%, or a medication-induced hyperkalemia.

Monitor for changes in blood pressure, serum creatinine, and serum potassium within 2–4 weeks of initiation or increase in the dose of an ACEi or ARB, and continue ACEi or ARB therapy unless serum creatinine rises by more than 30% within 4 weeks following initiation of treatment. These monitoring guidelines help ensure that the medications are working properly and not causing adverse effects.

Combination Therapy: What You Need to Know

You might wonder whether taking both an ACE inhibitor and an ARB together would provide even greater protection. However, research has shown this approach can be harmful. Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy.

Combination therapy with an ACE inhibitor and an ARB, or DRI, has not been found to be more effective than monotherapy with an ACE inhibitor or ARB, and may increase the risk of hyperkalemia or acute kidney injury. This is why current guidelines recommend using one or the other, but not both together.

Game-Changing Medications: SGLT2 Inhibitors

One of the most significant advances in diabetic kidney disease treatment in recent years has been the development and widespread adoption of SGLT2 inhibitors. These medications have revolutionized how we approach kidney protection in diabetes.

What Are SGLT2 Inhibitors?

Initial studies with SGLT2 inhibitors explored their utility in improving blood sugar control in patients with type II diabetes mellitus (T2DM) by virtue of increased urinary glucose excretion, but the beneficial effect of this class of medications are now known to go beyond their glucosuric effect, with independent cardiovascular and kidney benefits.

SGLT2 inhibitors work by blocking glucose reabsorption in the kidneys, causing excess glucose to be excreted in the urine. While this helps lower blood sugar, researchers discovered that these medications also provide substantial kidney and heart protection through mechanisms that go beyond glucose control.

Kidney Protection Benefits

First-line antiglycemic treatment for type 2 diabetes and CKD with eGFR as low as 30 mL per minute per 1.73 m2 should include metformin and an SGLT2 inhibitor to improve cardiovascular outcomes and limit CKD progression. This represents a major shift in treatment guidelines, elevating SGLT2 inhibitors to first-line status alongside metformin.

The SGLT2 inhibitor improves cardiovascular outcomes and limits kidney disease progression. These dual benefits make SGLT2 inhibitors particularly valuable for diabetic patients, who face elevated risks of both kidney disease and cardiovascular complications.

SGLT-2 inhibitor therapy should be carried out for as long as possible if tolerated, and should be continued even if eGFR falls below 20mL (/ min•1.73m2) until kidney replacement therapy is started. This guidance reflects the substantial benefits these medications provide even in advanced kidney disease.

FDA Approval and Clinical Use

Dapagliflozin received approval from the Food and Drug Administration (FDA) on April 30, 2022, for the purpose of mitigating the risk of renal decline, renal failure, cardiovascular mortality, and hospitalization due to heart failure in adult patients diagnosed with CKD. This approval marked a milestone in recognizing SGLT2 inhibitors as kidney-protective medications, not just diabetes drugs.

Important Safety Considerations

While SGLT2 inhibitors are generally well-tolerated, there are some important safety considerations. SGLT2 inhibitors are contraindicated for individuals with type 1 diabetes mellitus (T1DM) or those experiencing diabetic ketoacidosis, and the presence of glycosuria associated with this medication may elevate the risk of developing infections in the reproductive and urinary systems.

Patients taking SGLT2 inhibitors should be aware of symptoms of urinary tract infections and genital yeast infections, which are more common with these medications. Maintaining good hygiene and staying well-hydrated can help reduce these risks. If you develop symptoms of infection, contact your healthcare provider promptly.

Enhanced Tolerability of Other Medications

An additional benefit of SGLT2 inhibitors is their positive effect on the tolerability of other kidney-protective medications. The reduction in hyperkalaemia and fluid retention with SGLT2 inhibitors may enhance the tolerability and safety of other treatments. This means that SGLT2 inhibitors can help you tolerate higher doses of ACE inhibitors or ARBs, maximizing the kidney-protective benefits of your entire medication regimen.

Finerenone: A Novel Kidney-Protective Agent

Finerenone represents another major advance in diabetic kidney disease treatment. This medication works through a different mechanism than ACE inhibitors, ARBs, or SGLT2 inhibitors, providing complementary protection.

What Is Finerenone?

Finerenone, which is a nonsteroidal mineralocorticoid antagonist (MRA), is the only nonsteroidal MRA clinically proven to have renal and cardiovascular benefits, and it can rapidly reduce proteinuria and provide long-term renal protection in patients with diabetes treated with RASi.

Finerenone blocks mineralocorticoid receptors, which play a role in inflammation and fibrosis (scarring) in the kidneys. By blocking these receptors, finerenone helps prevent the progressive scarring that leads to kidney failure.

Who Should Consider Finerenone?

Finerenone is FDA-approved for those with type 2 diabetes-associated kidney disease who have an eGFR above 25 and a urine-albumin creatinine ratio above 30, and it may improve kidney and heart outcomes by preventing fibrosis or scarring of the kidneys.

If you have type 2 diabetes with evidence of kidney disease—specifically, if your kidney function tests show an eGFR above 25 and you have protein in your urine—finerenone may be an appropriate addition to your treatment regimen. This medication is typically used in combination with ACE inhibitors or ARBs, not as a replacement for them.

Guideline Recommendations

Both the 2024 American Diabetes Association (ADA) guidelines and the 2022 Kidney Disease: Improving Global Outcome (KDIGO) guidelines recommend the use of RASi in treating microalbuminuria and macroalbuminuria in patients with DKD; recommend the combination of SGLT2i for patients with T2D and CKD who have a UACR ≥ 200 mg/g creatinine and eGFR ≥ 20 mL/min·1.73 m2, supported by evidence level A.

The 2020 KDIGO guidelines recommend a combination of ACEi/ARB and MRAs to reduce urinary protein levels in patients with T2DKD, and the use of MRAs in treating patients with diabetes with CKD was further improved according to the 2022 KDIGO and 2024 ADA guidelines. These evolving guidelines reflect the growing body of evidence supporting finerenone's role in comprehensive kidney protection strategies.

GLP-1 Receptor Agonists: Beyond Blood Sugar Control

GLP-1 receptor agonists, originally developed for blood sugar control and weight management, have also demonstrated kidney-protective properties that make them valuable for diabetic patients with kidney concerns.

Kidney Protection Mechanisms

GLP-1 receptor agonists (GLP-1 RAs) have been shown to provide kidney protection through mechanisms that are independent of their hypoglycemic effects, including the inhibition of oxidative stress. This means that GLP-1 receptor agonists protect your kidneys through pathways beyond simply lowering blood sugar.

Some of the GLP-1 receptor agonists have a beneficial effect in reducing cardiovascular events, and GLP-1 receptor agonist trials are safe with an eGFR as low as 15 mL per minute per 1.73 m2, where they appear to reduce albuminuria and preserve eGFR. These medications can be used even in advanced kidney disease, providing benefits when many other diabetes medications must be discontinued or dose-adjusted.

Recent Clinical Trial Evidence

Recent research has strengthened the case for GLP-1 receptor agonists in diabetic kidney disease. Patients with type 2 diabetes and chronic kidney disease were randomly assigned to receive subcutaneous semaglutide at a dose of 1.0 mg weekly or placebo, with the primary outcome being major kidney disease events, a composite of the onset of kidney failure, at least a 50% reduction in the eGFR from baseline, or death from kidney-related or cardiovascular causes.

This landmark trial demonstrated that semaglutide, a GLP-1 receptor agonist, significantly reduced the risk of major kidney disease events in patients with type 2 diabetes and chronic kidney disease. These findings have important implications for treatment strategies and highlight the multifaceted benefits of GLP-1 receptor agonists.

Who Should Consider GLP-1 Receptor Agonists?

GLP-1 RAs are FDA-approved for those with type 2 diabetes to help produce insulin and lower glucose when taken with meals alongside proper diet and exercise, and this class of medications is especially recommended for people with kidney disease and coronary artery disease, including heart attack, coronary stents, or bypass surgery.

GLP-1 RA may be preferentially used in patients with obesity, T2D, and CKD to promote intentional weight loss. If you have type 2 diabetes with kidney disease and also struggle with obesity or have cardiovascular disease, GLP-1 receptor agonists may be particularly beneficial for you.

Important Drug Interactions and Precautions

GLP-1 RA should not be used in combination with dipeptidyl peptidase-4 (DPP-4) inhibitors. This is because both medication classes work through similar pathways, and combining them doesn't provide additional benefits while potentially increasing side effects.

The risk of hypoglycemia is generally low with GLP-1 RA when used alone, but risk is increased when GLP-1 RA is used concomitantly with other medications such as sulfonylureas or insulin, and the doses of sulfonylurea and/or insulin may need to be reduced. If you're taking insulin or sulfonylureas along with a GLP-1 receptor agonist, your doctor will likely need to adjust your doses to prevent low blood sugar episodes.

Metformin: Adjusting Doses for Kidney Function

Metformin has been a cornerstone of type 2 diabetes treatment for decades. However, kidney function significantly affects how this medication should be used.

Metformin Safety in Kidney Disease

Metformin is safe in patients with an eGFR above 45 mL per minute per 1.73 m2 unless risk for acute kidney injury is high, and the dose of metformin should be reduced when eGFR is less than 45 mL per minute per 1.73 m2 and discontinued when eGFR is less than 30 mL per minute per 1.73 m2 or in people treated with dialysis.

These guidelines are important because metformin is eliminated by the kidneys. When kidney function declines, metformin can accumulate in the body, potentially leading to a rare but serious condition called lactic acidosis. By adjusting doses based on kidney function or discontinuing the medication when kidney function is severely impaired, this risk is minimized.

When to Stop Metformin

People with acute kidney injury should stop or avoid taking metformin, and if you're already taking it, speak with your doctor before stopping; if your GFR is between 46 and 60, your dose should be reduced, and if it falls below 45, metformin should be stopped.

Never stop metformin on your own without consulting your healthcare provider. If your kidney function has declined to the point where metformin needs to be discontinued, your doctor will work with you to adjust your diabetes treatment regimen, potentially adding or increasing other medications to maintain good blood sugar control.

Combination Therapy: The Future of Diabetic Kidney Disease Treatment

Emerging evidence suggests that using multiple kidney-protective medications together may provide superior protection compared to any single medication alone.

The Four Pillars of Kidney Protection

Finerenone is a very welcome addition to our growing armamentarium, as we get closer to a guideline directed medical therapy for DKD, which would include an ACE-I or ARB, MRA, SGLT2 inhibitors, and possibly a GLP-1 agonist. This multi-drug approach represents a comprehensive strategy for kidney protection.

Each therapeutic class offers independent and additive benefits in diabetic kidney disease, regardless of background therapy. This means that combining medications from different classes can provide greater protection than any single medication alone, as each works through different mechanisms to protect your kidneys.

Evidence for Triple Therapy

Among patients with T2DM and moderate albuminuria (urinary albumin creatinine ratio UACR ≥ 30 mg/g), the three-drug combination of SGLT2i, GLP-1 RA, and ns-MRA resulted in a significant reduction in the risk of cardiovascular and kidney events, as well as an improvement in overall survival when compared to conventional treatment methods.

This research, published in a leading medical journal, demonstrates that carefully selected combination therapy can dramatically improve outcomes for diabetic patients with kidney disease. The key is using medications that work through complementary mechanisms, each contributing unique protective effects.

Regular Monitoring: The Foundation of Safe Medication Management

Regular monitoring of kidney function is essential for safe and effective medication management in diabetic patients. These tests help your healthcare team make informed decisions about your treatment.

Understanding Kidney Function Tests

CKD is defined as persistent eGFR <60 mL/min/1.73 m2, albuminuria (ACR ≥30 mg/g), or other markers of kidney damage, and persistence for at least 3 months is therefore required for diagnosis. Your kidney function is assessed through blood tests that measure creatinine levels and calculate your estimated glomerular filtration rate (eGFR), as well as urine tests that check for protein or albumin.

The eGFR tells your doctor how well your kidneys are filtering waste from your blood. A normal eGFR is typically above 90 mL/min/1.73 m². As this number decreases, it indicates declining kidney function. The albumin-to-creatinine ratio in your urine indicates whether protein is leaking through your kidney filters—an early sign of kidney damage.

Recommended Screening Schedule

Both the ADA and KDIGO recommend annual screening of patients with diabetes for CKD. This means that if you have diabetes, you should have your kidney function checked at least once a year, even if you feel fine and have no symptoms of kidney problems.

For most people, CKD is not identified as a result of symptoms; CKD is often diagnosed through routine screening. This underscores the importance of keeping up with your regular medical appointments and laboratory tests. Kidney disease often progresses silently, without obvious symptoms, until it reaches advanced stages. Regular screening allows for early detection and intervention when treatments are most effective.

Adjusting Medications Based on Kidney Function

As kidney function deteriorates and reaches lower GFR, changes to types and doses of medications often need to be adjusted, and management of anemia, bone and mineral disorders, fluid and electrolyte disturbances become increasingly dominant.

Your doctor will use your kidney function test results to determine appropriate medication doses and to decide whether certain medications should be continued, adjusted, or discontinued. This individualized approach ensures that you receive maximum benefit from your medications while minimizing risks of side effects or complications.

Monitoring for Medication Side Effects

Beyond kidney function tests, your healthcare team will monitor for specific side effects related to your medications. For example, ACE inhibitors and ARBs require monitoring of potassium levels, as these medications can cause potassium to accumulate in the blood. SGLT2 inhibitors require monitoring for signs of urinary tract infections. Your doctor will order appropriate tests based on your specific medication regimen.

Medications to Avoid: Protecting Your Kidneys from Harm

Just as important as knowing which medications to take is understanding which medications to avoid or use with extreme caution when you have diabetes and kidney concerns.

NSAIDs: A Major Kidney Risk

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used over-the-counter pain relievers, but they pose significant risks for people with diabetes and kidney disease. NSAIDs include medications like ibuprofen (Advil, Motrin), naproxen (Aleve), and many others.

NSAIDs can reduce blood flow to the kidneys, potentially causing acute kidney injury or worsening chronic kidney disease. They can also interfere with blood pressure control and reduce the effectiveness of ACE inhibitors and ARBs. For people with diabetes and kidney concerns, NSAIDs should generally be avoided unless specifically recommended by your healthcare provider for a compelling reason.

If you need pain relief, discuss safer alternatives with your doctor. Acetaminophen (Tylenol) is generally safer for the kidneys when used at recommended doses, though it should still be used cautiously and under medical guidance if you have liver problems.

Contrast Dye and Imaging Studies

Contrast dye used in certain imaging studies (CT scans, angiograms, and some other procedures) can be harmful to kidneys, particularly in people with diabetes or pre-existing kidney disease. This doesn't mean you can never have these tests, but it does mean that special precautions should be taken.

Before any imaging study that requires contrast dye, make sure the ordering physician and the radiology department know that you have diabetes and are aware of your current kidney function. They may take steps to minimize risk, such as ensuring you're well-hydrated before and after the procedure, using the minimum amount of contrast necessary, or choosing alternative imaging methods that don't require contrast.

Certain Antibiotics and Other Medications

Some antibiotics and other prescription medications can be harmful to kidneys or require dose adjustments based on kidney function. Always inform any healthcare provider who prescribes medications for you that you have diabetes and provide information about your kidney function if you know it.

Your pharmacist is also an excellent resource for identifying potential kidney-related concerns with new medications. Don't hesitate to ask your pharmacist whether a new medication is safe for your kidneys or whether it requires any special precautions.

Herbal Supplements and "Natural" Products

Many people assume that herbal supplements and natural products are safe, but this isn't always true, especially for people with kidney concerns. Some herbal products can damage kidneys or interact with your prescription medications in harmful ways.

Before taking any herbal supplement, vitamin, or over-the-counter product, discuss it with your healthcare provider or pharmacist. This includes products marketed for diabetes, weight loss, energy, or general health. What seems harmless could potentially interfere with your kidney-protective medications or cause direct kidney damage.

Medication Adherence: Taking Your Medications as Prescribed

Even the most effective medications can't protect your kidneys if you don't take them consistently and correctly. Medication adherence—taking your medications exactly as prescribed—is crucial for achieving the best possible outcomes.

Why Adherence Matters

Kidney protection requires consistent medication levels in your body. Missing doses or taking medications irregularly can lead to fluctuations in blood sugar and blood pressure, allowing kidney damage to progress. Many kidney-protective medications work by providing continuous blockade of harmful pathways—when you miss doses, that protection is interrupted.

Research consistently shows that patients who take their medications as prescribed have better outcomes, including slower progression of kidney disease, fewer complications, and better quality of life. Conversely, poor adherence is associated with faster decline in kidney function and increased risk of kidney failure.

Strategies for Improving Adherence

If you struggle to remember to take your medications, you're not alone. Here are some practical strategies that can help:

• Use a pill organizer: Weekly pill organizers with compartments for different times of day can help you keep track of whether you've taken your medications.
• Set phone alarms: Use your smartphone to set daily reminders for medication times.
• Link medications to daily routines: Take medications at the same time as other daily activities, like brushing your teeth or eating meals.
• Keep medications visible: Store medications where you'll see them regularly (but safely away from children and pets).
• Use a medication tracking app: Many smartphone apps are designed to help track medication schedules and send reminders.
• Simplify your regimen: Ask your doctor if any of your medications can be combined or if once-daily formulations are available to reduce the number of times you need to remember to take pills.
• Address cost concerns: If medication costs are a barrier, discuss this openly with your healthcare provider. Generic alternatives, patient assistance programs, or different medication choices may be available.

What to Do If You Miss a Dose

If you miss a dose of medication, don't panic. The best approach depends on the specific medication and how much time has passed. Generally, if you remember within a few hours of your usual time, take the missed dose. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Never double up on doses to make up for a missed one unless specifically instructed to do so by your healthcare provider.

For specific guidance about what to do if you miss a dose of any of your medications, ask your pharmacist or doctor. They can provide medication-specific instructions that you can keep for reference.

Communication with Your Healthcare Team

Effective communication with your healthcare providers is essential for optimal medication management and kidney protection.

Comprehensive Medication Lists

Maintain an up-to-date list of all medications you take, including prescription medications, over-the-counter drugs, vitamins, and supplements. Include the medication name, dose, and frequency. Bring this list to every medical appointment, and update it whenever changes are made.

This is particularly important if you see multiple healthcare providers. Your primary care doctor, endocrinologist, nephrologist, and any other specialists need to know about all medications you're taking to avoid dangerous interactions and ensure coordinated care.

Asking the Right Questions

Don't hesitate to ask questions about your medications. Important questions to consider include:

• What is this medication supposed to do?
• How and when should I take it?
• What side effects should I watch for?
• What should I do if I experience side effects?
• Are there any foods, drinks, or other medications I should avoid while taking this?
• How will we know if the medication is working?
• How long will I need to take this medication?
• What should I do if I miss a dose?
• Are there any special storage requirements?
• Is a generic version available?

If you have diabetes and kidney disease or early-stage kidney disease without diabetes, ask your doctor if you could benefit from any of these medications; if you have CKD with or without type 2 diabetes, ask if SGLT2 inhibitors are right for me; if you have CKD with type-2 diabetes, also ask if Finerenone, or GLP-1 receptor agonists, are right for me.

Reporting Side Effects and Concerns

If you experience side effects or have concerns about your medications, contact your healthcare provider promptly. Don't stop taking medications on your own without medical guidance, as this could lead to rapid deterioration in your condition.

Some side effects are minor and may improve with time, while others may require medication adjustments or changes. Your healthcare provider can help you determine whether what you're experiencing is a normal adjustment period or a sign that a medication change is needed.

Team-Based Care

Multi-morbidity is common among people with diabetes and CKD, and care usually involves many other specialties; with the patient at the center, the team includes medical doctors, nurses, dietitians, pharmacists, social workers, educators, lab technicians, podiatrists, family members, and potentially many others.

Optimal care includes primary care, cardiology, nephrology, endocrinology, psychology, nutrition, and disease management nursing support. Don't hesitate to take advantage of all the resources available to you. Each member of your healthcare team brings unique expertise that can contribute to your overall care.

The Role of Patient Education

Education is a powerful tool in managing diabetes and protecting kidney health. The more you understand about your condition and treatment, the better equipped you are to make informed decisions and take an active role in your care.

Structured Education Programs

A structured self-management educational program should be implemented for care of people with diabetes and CKD, and structured education is critical to engage people with diabetes and CKD to self-manage their disease and participate in the necessary shared decision-making regarding the management plan.

Structured education in diabetes self-management is recommended for people with diabetes and CKD because education improves long-term clinical outcomes and quality of life, and group-based education programs improve A1C level, fasting blood glucose level, body weight, self-efficacy, and patient satisfaction.

Ask your healthcare provider about diabetes education programs available in your area. Many hospitals, clinics, and community organizations offer classes specifically designed for people with diabetes. These programs can provide valuable information about medication management, blood sugar monitoring, nutrition, exercise, and other aspects of diabetes care.

Reliable Information Sources

When seeking information about diabetes and kidney disease, it's important to use reliable sources. Reputable organizations that provide evidence-based information include:

• American Diabetes Association (https://www.diabetes.org)
• National Kidney Foundation (https://www.kidney.org)
• National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov)
• Kidney Disease: Improving Global Outcomes (KDIGO) (https://kdigo.org)

Be cautious about information from commercial websites, social media, or sources that promote specific products. While peer support can be valuable, medical advice should always come from qualified healthcare professionals who know your individual situation.

Lifestyle Factors That Complement Medication Therapy

While medications are crucial for protecting kidney health in diabetes, they work best when combined with healthy lifestyle choices.

Blood Sugar Control

Maintaining blood sugar levels as close to target as safely possible is fundamental to preventing kidney damage. Work with your healthcare team to establish appropriate blood sugar targets for you. A1C targets may vary from less than 6.5% to less than 8%, depending on patient factors, including risk for hypoglycemia.

Monitor your blood sugar as recommended by your healthcare provider. Regular monitoring helps you understand how food, activity, stress, and medications affect your blood sugar, allowing you to make informed adjustments to keep levels in your target range.

Blood Pressure Management

Patients with diabetes and hypertension should be treated to a blood pressure goal of less than 140/80 mmHg. In addition to taking blood pressure medications as prescribed, lifestyle measures can help control blood pressure:

• Reduce sodium intake
• Maintain a healthy weight
• Exercise regularly
• Limit alcohol consumption
• Manage stress
• Get adequate sleep

Smoking Cessation

Cigarette smoking is associated with kidney disease progression, and patients should be advised to quit smoking. Smoking damages blood vessels throughout the body, including those in the kidneys, accelerating kidney disease progression. If you smoke, quitting is one of the most important things you can do to protect your kidneys.

Talk to your healthcare provider about smoking cessation resources. Medications, counseling, support groups, and other tools can significantly improve your chances of successfully quitting.

Nutrition and Kidney Health

Nutrition plays an important role in managing diabetes and protecting kidney health. A protein intake of 0.8–1.0 g/kg/day in patients with macroalbuminuria may improve urine albumin excretion rate, and such a diet may prove useful in reducing urinary protein excretion in patients with worsening nephropathy despite well-controlled blood pressure and blood glucose levels and optimal doses of ACE inhibitor or ARB therapy.

Working with a registered dietitian who specializes in diabetes and kidney disease can be extremely helpful. They can provide personalized nutrition recommendations that take into account your kidney function, blood sugar control, blood pressure, and other individual factors.

Physical Activity

Regular physical activity helps control blood sugar, manage weight, lower blood pressure, and improve overall cardiovascular health—all of which benefit your kidneys. Aim for at least 150 minutes of moderate-intensity aerobic activity per week, along with strength training exercises at least twice weekly.

Before starting a new exercise program, especially if you have complications from diabetes or kidney disease, consult with your healthcare provider to ensure you choose activities that are safe and appropriate for your condition.

Financial Considerations and Medication Access

The cost of medications can be a significant barrier to optimal treatment. However, resources are available to help make medications more affordable.

Discussing Cost Concerns

If medication costs are a concern, discuss this openly with your healthcare provider. They may be able to:

• Prescribe generic alternatives when available
• Choose equally effective medications that are less expensive
• Provide samples to help you get started on new medications
• Connect you with patient assistance programs
• Adjust your regimen to prioritize the most essential medications if you can't afford everything

Patient Assistance Programs

Kidney disease medications and treatments can be very expensive but help is available; use discount cards for discounts and speak with your healthcare team for help creating a plan to afford your medication; if you are struggling to afford your medication, you can apply for Social Security or participate in co-pay assistance programs.

Many pharmaceutical companies offer patient assistance programs that provide medications at reduced cost or even free to eligible patients. Your healthcare provider's office or a social worker can help you identify and apply for these programs.

Insurance Navigation

Understanding your insurance coverage and working within its parameters can help reduce costs. Some strategies include:

• Using preferred pharmacies in your insurance network
• Ordering 90-day supplies when possible for better pricing
• Asking about mail-order pharmacy options
• Understanding your plan's formulary (list of covered medications)
• Working with your doctor to request prior authorization when needed

Never skip or ration medications due to cost without discussing alternatives with your healthcare provider. The long-term costs of uncontrolled diabetes and kidney disease progression far exceed the cost of medications.

Special Considerations for Different Stages of Kidney Disease

Medication management strategies may need to be adjusted based on the stage of kidney disease.

Early Kidney Disease (Stages 1-2)

In the early stages of kidney disease, when kidney function is still relatively preserved, the focus is on prevention and slowing progression. This is the ideal time to start kidney-protective medications like ACE inhibitors or ARBs, SGLT2 inhibitors, and potentially other agents. Most diabetes medications can be used at standard doses in early kidney disease.

Moderate Kidney Disease (Stage 3)

As kidney function declines to moderate levels (eGFR 30-59 mL/min/1.73 m²), some medication adjustments become necessary. Metformin doses may need to be reduced, and certain other diabetes medications may require dose adjustments. However, kidney-protective medications like SGLT2 inhibitors should generally be continued, as they provide benefits even at this stage.

Advanced Kidney Disease (Stages 4-5)

In advanced kidney disease (eGFR below 30 mL/min/1.73 m²), medication management becomes more complex. Many diabetes medications must be discontinued or require significant dose reductions. However, some kidney-protective medications can and should be continued even at these advanced stages.

At this stage, you'll likely be under the care of a nephrologist (kidney specialist) who will work closely with your other healthcare providers to optimize your medication regimen. Additional medications may be needed to manage complications of advanced kidney disease, such as anemia, bone disease, and electrolyte imbalances.

Emerging Therapies and Future Directions

The field of diabetic kidney disease treatment continues to evolve rapidly, with new therapies and approaches under investigation.

Ongoing Clinical Trials

Recent advancements in novel therapeutics, stem cell therapies, and related fields provide promising new avenues for treatment, and the anticipation of further rigorous clinical investigations holds the potential to expand therapeutic options and enhance the well-being of DKD patients in the future.

Researchers are investigating new medications, new combinations of existing medications, and entirely novel approaches to preventing and treating diabetic kidney disease. Some areas of active research include:

• Endothelin receptor antagonists
• Novel anti-inflammatory agents
• Medications targeting kidney fibrosis
• Gene therapies
• Stem cell treatments

Personalized Medicine Approaches

Ongoing research seeks to define CKD subtypes with more granularity and link novel subtypes to precision treatments. The future of diabetic kidney disease treatment may involve more personalized approaches, where treatment is tailored based on specific characteristics of an individual's disease, genetic factors, and other biomarkers.

Staying Informed About New Treatments

As new treatments become available, discuss with your healthcare provider whether they might be appropriate for you. Recent clinical trials support new approaches to treat diabetes and CKD. Your healthcare team can help you understand new treatment options and determine whether changes to your medication regimen might be beneficial.

Comprehensive Medication Safety Tips

To maximize the benefits of your medications while minimizing risks, follow these comprehensive safety guidelines:

Essential Medication Safety Practices

• Take medications exactly as prescribed: Follow dosing instructions precisely, including timing, whether to take with food, and any other special instructions.
• Never stop medications without consulting your healthcare provider: Even if you feel better or experience side effects, don't discontinue medications on your own. Changes should be made under medical supervision.
• Keep an updated medication list: Include all prescription medications, over-the-counter drugs, vitamins, and supplements. Share this list with all healthcare providers.
• Inform all healthcare providers about your diabetes and kidney status: Any doctor, dentist, or other healthcare provider who treats you should know about your conditions.
• Avoid over-the-counter NSAIDs: These common pain relievers can harm kidneys. Use alternative pain management strategies or medications recommended by your doctor.
• Be cautious with herbal supplements: Many can interact with medications or harm kidneys. Always discuss supplements with your healthcare provider before taking them.
• Store medications properly: Follow storage instructions on medication labels. Some medications require refrigeration, while others should be kept at room temperature away from moisture and heat.
• Check expiration dates: Don't use medications past their expiration dates, as they may lose effectiveness or become harmful.
• Use one pharmacy when possible: Having all your prescriptions filled at the same pharmacy allows pharmacists to screen for drug interactions and maintain complete records.
• Report side effects promptly: Contact your healthcare provider if you experience unusual symptoms or side effects from medications.
• Attend all scheduled appointments: Regular follow-up visits and laboratory tests are essential for monitoring your condition and adjusting medications as needed.
• Ask questions: If you don't understand something about your medications, ask your doctor or pharmacist for clarification.
• Plan ahead for refills: Don't wait until you're completely out of medication to request refills. Order refills a few days early to avoid gaps in therapy.
• Be prepared for emergencies: Keep a list of your medications with you at all times. Consider wearing a medical alert bracelet indicating you have diabetes.
• Dispose of medications properly: Don't flush medications down the toilet or throw them in the trash. Use medication take-back programs or follow FDA guidelines for safe disposal.

When to Contact Your Healthcare Provider

Contact your healthcare provider promptly if you experience:

• Severe or persistent side effects from medications
• Signs of allergic reaction (rash, itching, swelling, difficulty breathing)
• Significant changes in blood sugar patterns
• Symptoms of low blood sugar (shakiness, sweating, confusion, rapid heartbeat)
• Symptoms of high blood sugar (excessive thirst, frequent urination, blurred vision)
• Changes in urination patterns (frequency, amount, appearance)
• Swelling in legs, ankles, or feet
• Unexplained weight gain or loss
• Persistent nausea or vomiting
• Unusual fatigue or weakness
• Chest pain or shortness of breath
• Any other concerning symptoms

The Importance of a Comprehensive Care Approach

Multimorbidity is common in patients with diabetes and CKD, who are at high risk of CKD progression, cardiovascular events, and premature mortality, and both the ADA and KDIGO emphasize the importance of comprehensive, holistic, patient-centered medical care to improve overall patient outcomes.

Patients with diabetes and chronic kidney disease (CKD) should be treated with a comprehensive strategy to reduce risks of kidney disease progression and cardiovascular disease. This comprehensive approach includes not just medications, but also lifestyle modifications, regular monitoring, patient education, and coordinated care among multiple healthcare providers.

Protecting your kidneys when you have diabetes requires a multifaceted approach. Medications are powerful tools, but they work best as part of an overall strategy that includes healthy lifestyle choices, regular medical care, and active patient engagement in self-management.

Conclusion: Taking Control of Your Kidney Health

Managing medications effectively is one of the most important things you can do to protect your kidney health when you have diabetes. The landscape of diabetic kidney disease treatment has changed dramatically in recent years, with multiple new medication classes offering unprecedented opportunities for kidney protection.

We are fortunate to be living in an era where we are able to offer intervention, not only to slow down the progression of DKD, but also prevent cardiovascular complications and improve survival. By understanding your medications, taking them as prescribed, attending regular medical appointments, monitoring your kidney function, avoiding harmful substances, and maintaining healthy lifestyle habits, you can significantly reduce your risk of kidney disease progression.

Remember that you are the most important member of your healthcare team. Your daily choices and actions have a profound impact on your kidney health. Stay informed, ask questions, communicate openly with your healthcare providers, and take an active role in your care. With the right medications, proper management, and a comprehensive approach to your health, you can protect your kidneys and maintain your quality of life for years to come.

If you haven't already discussed the newer kidney-protective medications with your healthcare provider, consider scheduling an appointment to review your current medication regimen and explore whether any adjustments might benefit you. The field continues to advance rapidly, and staying current with treatment options ensures you receive the best possible care for protecting your kidney health.